Analyst Ratings for Rapport Therapeutics (RAPP)
RAPP Rating Summary
RAPP Price Target Summary
- Highest: $80.00 (Citizens)
- Lowest: $40.00 (H.C. Wainwright)
- Average: $55.60
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$55.60 (+30.5%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/24/2026 | Leerink | Marc Goodman | New Coverage | Outperform (N/A) |
52.00 (N/A) |
38.88 (42.62) |
9.62% | Details |
| 5/18/2026 | Truist Securities | Danielle Brill | New Coverage | Buy (N/A) |
56.00 (N/A) |
37.07 (42.62) |
14.97% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
